CN116584661A - 用于身体机能修复的小分子复合肽配方及用途、食用方法 - Google Patents
用于身体机能修复的小分子复合肽配方及用途、食用方法 Download PDFInfo
- Publication number
- CN116584661A CN116584661A CN202310704504.0A CN202310704504A CN116584661A CN 116584661 A CN116584661 A CN 116584661A CN 202310704504 A CN202310704504 A CN 202310704504A CN 116584661 A CN116584661 A CN 116584661A
- Authority
- CN
- China
- Prior art keywords
- peptide
- small molecule
- cells
- liver
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 91
- 230000006870 function Effects 0.000 title claims abstract description 22
- -1 small molecule compound Chemical class 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title claims abstract description 10
- 150000003384 small molecules Chemical class 0.000 claims abstract description 24
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 16
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 13
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 13
- 241000208340 Araliaceae Species 0.000 claims abstract description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 8
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 8
- 239000011718 vitamin C Substances 0.000 claims abstract description 8
- 235000010447 xylitol Nutrition 0.000 claims abstract description 8
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 8
- 239000000811 xylitol Substances 0.000 claims abstract description 8
- 229960002675 xylitol Drugs 0.000 claims abstract description 8
- 241000251468 Actinopterygii Species 0.000 claims abstract description 7
- 102000008186 Collagen Human genes 0.000 claims abstract description 7
- 108010035532 Collagen Proteins 0.000 claims abstract description 7
- 241000157862 Dicamptodontidae Species 0.000 claims abstract description 7
- 229920001436 collagen Polymers 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 230000001502 supplementing effect Effects 0.000 claims abstract description 5
- 235000014268 sports nutrition Nutrition 0.000 claims abstract description 4
- 230000008439 repair process Effects 0.000 claims description 7
- 244000010000 Hovenia dulcis Species 0.000 claims description 6
- 235000008584 Hovenia dulcis Nutrition 0.000 claims description 6
- 244000046146 Pueraria lobata Species 0.000 claims description 6
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 6
- 235000013361 beverage Nutrition 0.000 claims description 3
- 235000015203 fruit juice Nutrition 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 235000013618 yogurt Nutrition 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims 5
- 210000005229 liver cell Anatomy 0.000 abstract description 29
- 210000004185 liver Anatomy 0.000 abstract description 26
- 210000004027 cell Anatomy 0.000 abstract description 22
- 235000016709 nutrition Nutrition 0.000 abstract description 15
- 230000012010 growth Effects 0.000 abstract description 5
- 230000035790 physiological processes and functions Effects 0.000 abstract description 5
- 230000035755 proliferation Effects 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 4
- 230000001172 regenerating effect Effects 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000019522 cellular metabolic process Effects 0.000 abstract 2
- 210000000582 semen Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 16
- 230000004060 metabolic process Effects 0.000 description 16
- 230000015572 biosynthetic process Effects 0.000 description 11
- 230000036039 immunity Effects 0.000 description 11
- 208000019425 cirrhosis of liver Diseases 0.000 description 10
- 206010016654 Fibrosis Diseases 0.000 description 9
- 230000008030 elimination Effects 0.000 description 9
- 238000003379 elimination reaction Methods 0.000 description 9
- 210000003494 hepatocyte Anatomy 0.000 description 9
- 230000003908 liver function Effects 0.000 description 9
- 230000035764 nutrition Effects 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 8
- 230000006378 damage Effects 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 7
- 208000019423 liver disease Diseases 0.000 description 7
- 150000003254 radicals Chemical class 0.000 description 7
- 102000009027 Albumins Human genes 0.000 description 6
- 108010088751 Albumins Proteins 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000007882 cirrhosis Effects 0.000 description 6
- 208000006454 hepatitis Diseases 0.000 description 6
- 231100000283 hepatitis Toxicity 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 230000003902 lesion Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000000601 blood cell Anatomy 0.000 description 4
- 210000004958 brain cell Anatomy 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 210000003890 endocrine cell Anatomy 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 210000004602 germ cell Anatomy 0.000 description 4
- 210000000663 muscle cell Anatomy 0.000 description 4
- 210000002569 neuron Anatomy 0.000 description 4
- 210000004927 skin cell Anatomy 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 208000018380 Chemical injury Diseases 0.000 description 3
- 230000006820 DNA synthesis Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 208000004930 Fatty Liver Diseases 0.000 description 3
- 206010019668 Hepatic fibrosis Diseases 0.000 description 3
- 206010019708 Hepatic steatosis Diseases 0.000 description 3
- 241000700721 Hepatitis B virus Species 0.000 description 3
- 206010067125 Liver injury Diseases 0.000 description 3
- 102000007562 Serum Albumin Human genes 0.000 description 3
- 108010071390 Serum Albumin Proteins 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 239000012645 endogenous antigen Substances 0.000 description 3
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 3
- 208000010706 fatty liver disease Diseases 0.000 description 3
- 230000004761 fibrosis Effects 0.000 description 3
- 231100000753 hepatic injury Toxicity 0.000 description 3
- 210000004024 hepatic stellate cell Anatomy 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 230000003859 lipid peroxidation Effects 0.000 description 3
- 210000001700 mitochondrial membrane Anatomy 0.000 description 3
- 210000000822 natural killer cell Anatomy 0.000 description 3
- 239000012466 permeate Substances 0.000 description 3
- 210000001539 phagocyte Anatomy 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 238000001959 radiotherapy Methods 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 231100000240 steatosis hepatitis Toxicity 0.000 description 3
- 206010047623 Vitamin C deficiency Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 208000010233 scurvy Diseases 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000019926 Keshan disease Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 210000001953 common bile duct Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000000514 hepatopancreas Anatomy 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 208000022760 infectious otitis media Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003307 reticuloendothelial effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种用于身体机能修复的小分子复合肽配方及用途、食用方法,主要涉及一种运动营养食品。包括大鲵肽、鱼胶原蛋白肽、葛根肽、枳椇子肽、人参粉、木糖醇、维生素C。上述小分子复合肽配方的用途:用于作为运动营养补充蛋白质使用。上述小分子复合肽配方的食用方法,用40℃以下温水冲调食用。本发明的有益效果在于:能直接介入细胞的新陈代谢,参与细胞的生长、发育、生理功能以及***增殖各个环节;修复人体变性的细胞来改善细胞新陈代谢,把长期在休眠状态的细胞保持在活跃的状态并且去除对人体危害的自由基的作用。利用小分子肽的优势来恢复、增强身体机能。对于肝脏而言,能够为受损肝细胞的修复和再生提供全面的营养支持。
Description
技术领域
本发明涉及一种运动营养食品,具体是一种用于身体机能修复的小分子复合肽配方及用途、食用方法。
背景技术
人体每天细胞组织的更新、构成及修补,保证机体正常运作,都需要蛋白质的参与。消瘦、浮肿,长期缺乏可导致患病。蛋白质如此重要,人除了饮食外,每天还必须补充10克蛋白质,以保障人体新陈代谢及生理活动。所以,要想保持健康“肽”是构成人体细胞的基本材料。
肽是一种高活性、高营养、小分子、全吸收的一种物质。介于氨基酸和蛋白质之间,存在于人体的每一个角落,从头发丝到脚后跟都有肽的存在。蛋白质被摄入人体后,经过分解主要以氨基酸和小分子肽的形式被吸收和为细胞所利用。小分子肽,直接介入血细胞、脑和神经细胞、肌肉细胞、生殖细胞、内分泌细胞、皮肤细胞的新陈代谢,参与细胞的生长、发育、生理功能以及***增殖各个环节。因此,小分子肽有修复人体变性的细胞来改善细胞新陈代谢,促进新陈代谢,增强人体的免疫力,激活细胞,把长期在休眠状态的细胞保持在活跃的状态并且去除对人体危害的自由基的作用。
此外,肝脏是人体消化***中最大的消化腺,人体从食物中摄取的蛋白质、糖、脂肪和维生素等营养物质,最终是在肝脏或肝脏的参与下完成代谢的,所以肝脏被称为“加工厂”。此外,肝细胞能生成胆汁,通过胆囊管和胆总管把胆汁***到小肠,以此帮助食物消化吸收。时,肝脏也是人体最大的解毒器官,负责分解人体吸收的有毒物质;它也人体最大的网状内皮细胞吞噬***,具有吞噬细菌和病毒的作用,同时还能参与免疫调节、炎症反应以及调控组织和基质修复等功能。现代人生活节奏快、压力大、过度劳累、过度饮酒、环境污染以及摄入药物的毒副作用,常常会造成肝脏负担过重,远远超过了人体正常肝细胞的解读和恢复能力,肝细胞的内膜***就会逐渐失去稳定性而受到不同程度的破坏,从而出现肝细胞疏松、空泡化,甚至坏死。如果不及时治疗,就容易变成肝硬化、肝腹水,甚至变成肝癌,危及生命。
因而,现提出一种运动后调理机体营养的复合小分子肽配方,其营养丰富,具有多种生理活性,通过利用小分子肽的优势来恢复、增强身体机能、保护肝脏免受损伤。
发明内容
本发明的目的在于提供一种用于身体机能修复的小分子复合肽配方及用途、食用方法,它能直接介入血细胞、脑和神经细胞、肌肉细胞、生殖细胞、内分泌细胞、皮肤细胞的新陈代谢,参与细胞的生长、发育、生理功能以及***增殖各个环节;修复人体变性的细胞来改善细胞新陈代谢,促进新陈代谢,增强人体的免疫力,激活细胞,把长期在休眠状态的细胞保持在活跃的状态并且去除对人体危害的自由基的作用。其营养丰富,具有多种生理活性,人体通过利用小分子肽的优势来恢复、增强身体机能。对于肝脏而言,能够为受损肝细胞的修复和再生提供全面的营养支持。可以直接渗透到肝细胞,刺激肝细胞DNA合成,促进肝细胞再生,从而恢复肝功能。小分子肽具有抗脂质过氧化和清除自由基的作用,能够保护肝细胞、线粒体膜和内质网免受酒精或其他化学性损伤。小分子肽能全面提高肝脏的免疫力,对吞噬细胞、T细胞、NK细胞均具有免疫增强作用,消除各种外来入侵和内源性的抗原物质。比如清除血液中已经存在的乙肝病毒,清除侵入肝细胞内的肝炎病毒,甚至清除已经被感染病变的肝细胞。当肝脏中的白蛋白合成、运输发生障碍时,会引起血清白蛋白含量下降,造成肝硬化病变。而小分子肽可以提升肝脏白蛋白的合成能力,从而防止肝硬化的形成。小分子肽能改善肝细胞的功能和活力,促进脂肪代谢运转,清除肝脏周围的脂肪。小分子肽能减少损伤后肝细胞释放的可溶性致纤维化因子,减少肝星状细胞活化,抑制肝纤维化的发生发展。小分子肽可以清除或减轻放化疗对肿瘤病人的肝脏毒副作用。小分子肽不仅对肝细胞有良好的营养作用,而且能够保护肝脏细胞免受各种损伤。无论是肝功能正常的普通人,还是患有肝炎、肝硬化、脂肪肝等各种肝病的患者,都可以通过摄入小分子肽,减轻或消除肝损伤,使肝功能恢复正常。
本发明为实现上述目的,通过以下技术方案实现:
一种用于身体机能修复的小分子复合肽配方,包括以下组分:小分子肽、人参粉、木糖醇、维生素C。所述小分子肽包括大鲵肽、鱼胶原蛋白肽、葛根肽、枳椇子肽。各组分重量配比为:大鲵肽30份、人参粉5份、鱼胶原蛋白肽30份、葛根肽7份、枳椇子肽20份、木糖醇2份、维生素C6份。
上述小分子复合肽配方的用途:用于作为运动营养补充蛋白质使用。
上述小分子复合肽配方的食用方法,用40℃以下温水冲调食用。也可以用40℃以下温水、并搭配果汁、饮料、酸奶搅拌冲调食用。
对比现有技术,本发明的有益效果在于:
本发明所述的运动后调理机体营养的复合小分子肽配方过小分子肽易于吸收,能够快速地促进蛋白质合成,可以提高矿物质及微量元素的吸收率,由于小分子肽由多种氨基酸通过不同的肽键组合,故其具有极强的活性和多样性,可充分调理、增强、稳定人体的生理机能,增强人体生理活性。本发明能直接介入血细胞、脑和神经细胞、肌肉细胞、生殖细胞、内分泌细胞、皮肤细胞的新陈代谢,参与细胞的生长、发育、生理功能以及***增殖各个环节;修复人体变性的细胞来改善细胞新陈代谢,促进新陈代谢,增强人体的免疫力,激活细胞,把长期在休眠状态的细胞保持在活跃的状态并且去除对人体危害的自由基的作用。人体通过利用小分子肽的优势来恢复、增强身体机能。
对于肝脏而言,能够为受损肝细胞的修复和再生提供全面的营养支持。可以直接渗透到肝细胞,刺激肝细胞DNA合成,促进肝细胞再生,从而恢复肝功能。小分子肽具有抗脂质过氧化和清除自由基的作用,能够保护肝细胞、线粒体膜和内质网免受酒精或其他化学性损伤。小分子肽能全面提高肝脏的免疫力,对吞噬细胞、T细胞、NK细胞均具有免疫增强作用,消除各种外来入侵和内源性的抗原物质。比如清除血液中已经存在的乙肝病毒,清除侵入肝细胞内的肝炎病毒,甚至清除已经被感染病变的肝细胞。当肝脏中的白蛋白合成、运输发生障碍时,会引起血清白蛋白含量下降,造成肝硬化病变。而小分子肽可以提升肝脏白蛋白的合成能力,从而防止肝硬化的形成。小分子肽能改善肝细胞的功能和活力,促进脂肪代谢运转,清除肝脏周围的脂肪。小分子肽能减少损伤后肝细胞释放的可溶性致纤维化因子,减少肝星状细胞活化,抑制肝纤维化的发生发展。小分子肽可以清除或减轻放化疗对肿瘤病人的肝脏毒副作用。小分子肽不仅对肝细胞有良好的营养作用,而且能够保护肝脏细胞免受各种损伤。无论是肝功能正常的普通人,还是患有肝炎、肝硬化、脂肪肝等各种肝病的患者,都可以通过摄入小分子肽,减轻或消除肝损伤,使肝功能恢复正常。
具体实施方式
下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。此外应理解,在阅读了本发明讲授的内容之后,本领域技术人员可以对本发明作各种改动或修改,这些等价形式同样落于本申请所限定的范围。
一种用于身体机能修复的小分子复合肽配方,包括以下组分:、人参粉、木糖醇、维生素C、大鲵肽、鱼胶原蛋白肽、葛根肽、枳椇子肽。各组分重量配比为:大鲵肽30份、人参粉5份、鱼胶原蛋白肽30份、葛根肽7份、枳椇子肽20份、木糖醇2份、维生素C6份。上述小分子复合肽配方的用途:用于作为运动营养补充蛋白质使用。上述小分子复合肽配方的食用方法,用40℃以下温水冲调食用。也可以用40℃以下温水、并搭配果汁、饮料、酸奶搅拌冲调食用。
本发明所述的运动后调理机体营养的复合小分子肽配方过小分子肽易于吸收,能够快速地促进蛋白质合成,可以提高矿物质及微量元素的吸收率,由于小分子肽由多种氨基酸通过不同的肽键组合,故其具有极强的活性和多样性,可充分调理、增强、稳定人体的生理机能,增强人体生理活性。人参粉能够防止衰老,对于女性患者有美容养颜的作用,可以保持皮肤的水分和弹性,预防黄褐斑以及皮肤皱纹的出现。还能够大补元气,并且安神益智,对于气虚类疾病有较好的治疗效果,并且对于失眠、心悸、心慌、乏力等症状有明确的缓解作用。还能够治疗厌食症以及提高人体的免疫力、预防感冒和其他一些相关的治疗作用。还能够治疗糖尿病、缓解心律失常以及脑血管疾病、降低血脂、缓解消化不良等等。木糖醇能够适宜用作糖尿病患者的糖代用品,对***患者、胰岛素抵抗者补充热量。也可预防龋齿和急性中耳炎。维生素C能够治疗和预防维生素C缺乏症。常见有防治坏血病、感染性疾病,治疗克山病急性发作、肝脏疾病,以及各种贫血、过敏性皮肤病,促进伤口愈合,也用于某些癌症、高脂血症、酸化尿液等。
本发明能直接介入血细胞、脑和神经细胞、肌肉细胞、生殖细胞、内分泌细胞、皮肤细胞的新陈代谢,参与细胞的生长、发育、生理功能以及***增殖各个环节;修复人体变性的细胞来改善细胞新陈代谢,促进新陈代谢,增强人体的免疫力,激活细胞,把长期在休眠状态的细胞保持在活跃的状态并且去除对人体危害的自由基的作用。人体通过利用小分子肽的优势来恢复、增强身体机能。
对于肝脏而言,能够为受损肝细胞的修复和再生提供全面的营养支持。可以直接渗透到肝细胞,刺激肝细胞DNA合成,促进肝细胞再生,从而恢复肝功能。小分子肽具有抗脂质过氧化和清除自由基的作用,能够保护肝细胞、线粒体膜和内质网免受酒精或其他化学性损伤。小分子肽能全面提高肝脏的免疫力,对吞噬细胞、T细胞、NK细胞均具有免疫增强作用,消除各种外来入侵和内源性的抗原物质。比如清除血液中已经存在的乙肝病毒,清除侵入肝细胞内的肝炎病毒,甚至清除已经被感染病变的肝细胞。当肝脏中的白蛋白合成、运输发生障碍时,会引起血清白蛋白含量下降,造成肝硬化病变。而小分子肽可以提升肝脏白蛋白的合成能力,从而防止肝硬化的形成。小分子肽能改善肝细胞的功能和活力,促进脂肪代谢运转,清除肝脏周围的脂肪。小分子肽能减少损伤后肝细胞释放的可溶性致纤维化因子,减少肝星状细胞活化,抑制肝纤维化的发生发展。小分子肽可以清除或减轻放化疗对肿瘤病人的肝脏毒副作用。小分子肽不仅对肝细胞有良好的营养作用,而且能够保护肝脏细胞免受各种损伤。无论是肝功能正常的普通人,还是患有肝炎、肝硬化、脂肪肝等各种肝病的患者,都可以通过摄入小分子肽,减轻或消除肝损伤,使肝功能恢复正常。
具体的:
本发明所述小分子复合肽配方是用于补充蛋白质的运动人群,孕妇、哺乳期妇女及14岁以下儿童不适宜使用,人参粉可以为五年及五年以下的人工种植人参,保存环境应密闭、阴凉。
Claims (6)
1.一种用于身体机能修复的小分子复合肽配方,其特征在于:包括以下组分:小分子肽、人参粉、木糖醇、维生素C。
2.根据权利要求1所述一种用于身体机能修复的小分子复合肽配方,其特征在于:所述小分子肽包括大鲵肽、鱼胶原蛋白肽、葛根肽、枳椇子肽。
3.根据权利要求2所述一种用于身体机能修复的小分子复合肽配方,其特征在于:各组分重量配比为:大鲵肽30份、人参粉5份、鱼胶原蛋白肽30份、葛根肽7份、枳椇子肽20份、木糖醇2份、维生素C6份。
4.一种权利要求1-3任意一项所述一种用于身体机能修复的小分子复合肽配方的用途,其特征在于:用于作为运动营养补充蛋白质使用。
5.一种权利要求1-3任意一项所述一种用于身体机能修复的小分子复合肽配方的食用方法,其特征在于:用40℃以下温水冲调食用。
6.根据权利要求5所述一种用于身体机能修复的小分子复合肽配方的食用方法,其特征在于:用40℃以下温水、并搭配果汁、饮料、酸奶搅拌冲调食用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310704504.0A CN116584661A (zh) | 2023-06-14 | 2023-06-14 | 用于身体机能修复的小分子复合肽配方及用途、食用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310704504.0A CN116584661A (zh) | 2023-06-14 | 2023-06-14 | 用于身体机能修复的小分子复合肽配方及用途、食用方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116584661A true CN116584661A (zh) | 2023-08-15 |
Family
ID=87593810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310704504.0A Pending CN116584661A (zh) | 2023-06-14 | 2023-06-14 | 用于身体机能修复的小分子复合肽配方及用途、食用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116584661A (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103385437A (zh) * | 2013-06-28 | 2013-11-13 | 江苏农林职业技术学院 | 一种葛根功能性食品及其制备方法 |
CN106086143A (zh) * | 2016-08-23 | 2016-11-09 | 慈晓丽 | 一种葛根肽的制备方法 |
CN110652005A (zh) * | 2019-09-25 | 2020-01-07 | 上海诺德生物实业有限公司 | 一种酶解法制备枳椇子提取物的方法 |
CN112314829A (zh) * | 2020-09-24 | 2021-02-05 | 张家界金鲵生物工程股份有限公司 | 一种大鲵胶原蛋白肽固体饮料及其制备方法 |
CN113966802A (zh) * | 2021-10-22 | 2022-01-25 | 深圳荣耀植物智能科学有限公司 | 一种胶原蛋白肽饮品及其制作方法 |
CN114009795A (zh) * | 2021-11-16 | 2022-02-08 | 陕西语泽生物医药有限公司 | 一种保护肝脏的大鲵肽营养组合物 |
WO2022039480A1 (ko) * | 2020-08-20 | 2022-02-24 | (주)블랙진생코리아 | 흑삼농축액과 체리농축액이 포함된 건강보조식품 및 그 제조방법 |
-
2023
- 2023-06-14 CN CN202310704504.0A patent/CN116584661A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103385437A (zh) * | 2013-06-28 | 2013-11-13 | 江苏农林职业技术学院 | 一种葛根功能性食品及其制备方法 |
CN106086143A (zh) * | 2016-08-23 | 2016-11-09 | 慈晓丽 | 一种葛根肽的制备方法 |
CN110652005A (zh) * | 2019-09-25 | 2020-01-07 | 上海诺德生物实业有限公司 | 一种酶解法制备枳椇子提取物的方法 |
WO2022039480A1 (ko) * | 2020-08-20 | 2022-02-24 | (주)블랙진생코리아 | 흑삼농축액과 체리농축액이 포함된 건강보조식품 및 그 제조방법 |
CN112314829A (zh) * | 2020-09-24 | 2021-02-05 | 张家界金鲵生物工程股份有限公司 | 一种大鲵胶原蛋白肽固体饮料及其制备方法 |
CN113966802A (zh) * | 2021-10-22 | 2022-01-25 | 深圳荣耀植物智能科学有限公司 | 一种胶原蛋白肽饮品及其制作方法 |
CN114009795A (zh) * | 2021-11-16 | 2022-02-08 | 陕西语泽生物医药有限公司 | 一种保护肝脏的大鲵肽营养组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE102008036954B4 (de) | Verwendung einer Aminozucker enthaltenden Zusammensetzung | |
CN106072573A (zh) | 一种适用于老年肌肉衰减症食用的特膳食品 | |
US8124139B2 (en) | Compound preparation for quickly reducing oxidative stress and preparation of the same | |
CN104223107B (zh) | 一种护肝解酒排毒的保健品 | |
CN104041828B (zh) | 黑枸杞美白祛斑片 | |
CN103805418A (zh) | 一种海参酒 | |
CN105918387A (zh) | 一种适用中老年保健食品及制备方法 | |
JPH11332527A (ja) | 燕の巣のエキス製造方法及び燕の巣入り健康食品、 化粧品等 | |
CN102048225A (zh) | 一种具有改善生长发育功能的红枣保健饮料 | |
CN1900255A (zh) | 男性健美长寿液 | |
WO2013029034A1 (en) | Tripartite bioactive composition providing anti-oxidant and anti-inflammatory effects with immune system and stem cell production enhancement | |
CN116584661A (zh) | 用于身体机能修复的小分子复合肽配方及用途、食用方法 | |
CN100506085C (zh) | 一种能够提高产妇免疫力的红糖保健品 | |
KR102428634B1 (ko) | 굼벵이 유동충 과립 제조방법 | |
KR102322276B1 (ko) | 비만 예방 및 부종 개선용 음료 조성물 | |
CN103932941A (zh) | 营养元素抗衰护肤液 | |
CN109258976A (zh) | 一种鸡饲料中的中药添加剂 | |
CN109452418A (zh) | 一种纯天然美颜排毒茶饮料及其制备方法 | |
CN1814282A (zh) | 生物胶原蛋白口服液及其制备方法 | |
KR101110236B1 (ko) | 비타민 함유 저온나노추출 발모촉진제 및 그 제조방법 | |
CN106213157A (zh) | 超级藜麦学生营养包制作工艺 | |
KR20220050279A (ko) | 식용곤충을 이용한 기능성 발효 조성물의 제조방법 및 그에 따라 제조된 기능성 발효 조성물 | |
CN106581663A (zh) | 一种治疗激素依赖性皮炎的组合物 | |
CN116712534A (zh) | 一种具有美容养颜功能的养生组合物及其制备方法 | |
CN118141111A (zh) | 一种延年益寿的组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |